Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk

Brandon Brown; Tonia Poteat; Logan Marg; Jerome T Galea

doi:10.1089/lgbt.2016.0142

Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk

Brandon Brown, Tonia Poteat, Logan Marg, Jerome T Galea

Research output: Contribution to journal › Article › peer-review

Abstract

Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

Original language	American English
Journal	LGBT Health
Volume	4
DOIs	https://doi.org/10.1089/lgbt.2016.0142
State	Published - Oct 1 2017
Externally published	Yes

Keywords

cancer screening
gender identity
HPV
HPV vaccine
prevention
transgender

Disciplines

Social and Behavioral Sciences
Social Work

Access to Document

10.1089/lgbt.2016.0142License: CC BY

https://doi.org/10.1089/lgbt.2016.0142

Cite this

@article{8bdf6e51154d4fa0885fc0928a2ef0f3,

title = "Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk",

abstract = " Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.",

keywords = "cancer screening, gender identity, HPV, HPV vaccine, prevention, transgender",

author = "Brandon Brown and Tonia Poteat and Logan Marg and Galea, {Jerome T}",

year = "2017",

month = oct,

day = "1",

doi = "10.1089/lgbt.2016.0142",

language = "American English",

volume = "4",

journal = "LGBT Health",

}

TY - JOUR

T1 - Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk

AU - Brown, Brandon

AU - Poteat, Tonia

AU - Marg, Logan

AU - Galea, Jerome T

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

AB - Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

KW - cancer screening

KW - gender identity

KW - HPV

KW - HPV vaccine

KW - prevention

KW - transgender

UR - https://digitalcommons.usf.edu/sok_facpub/14

UR - https://doi.org/10.1089/lgbt.2016.0142

U2 - 10.1089/lgbt.2016.0142

DO - 10.1089/lgbt.2016.0142

M3 - Article

C2 - 28876211

VL - 4

JO - LGBT Health

JF - LGBT Health

ER -

Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this